John L. Brottem sold $2,562 of OM
General Counsel at Outset Medical, Inc.. 3,203 shares at an average of $0.80, traded Nov 15, 2024, filed Nov 18, 2024.
Score components
- +15RoleOfficer
- 0Trade size$3k at market
- 0Share of holdings soldSold 1.4% of holdings
- +15Cluster4 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +46.1%, 3m +28.8%, 6m +87.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001484612-24-000072, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 15, 2024 | SOpen-market sale Common Stock | -3,203 | $0.80 | $2,562 | 227,092 | Nov 18, 2024 |
Related signals
Other insiders at Outset Medical, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 41Moderate | OMbuy Outset Medical, Inc. | Braden Michael Leonard owner | $870k 244,909 shares | +10% | |
| 35Weak | Outset Medical, Inc. | Karen Drexler director | $6,765 1,548 shares | -13% | |
| 30Weak | Outset Medical, Inc. | John L. Brottem General Counsel | $1,785 388 shares | -1% | |
| 30Weak | Outset Medical, Inc. | Marc Nash EVP Operations R&D & Service | $1,136 247 shares | -1% | |
| 40Moderate | Outset Medical, Inc. | Leslie Trigg Chair and CEO | $4,214 916 shares | -1% | |
| 30Weak | Outset Medical, Inc. | John L. Brottem General Counsel | $4,933 383 shares | -1% | |
| 30Weak | Outset Medical, Inc. | Marc Nash SVP Operations and R&D | $3,130 243 shares | -1% | |
| 40Moderate | Outset Medical, Inc. | Leslie Trigg Chair and CEO | $12k 904 shares | -1% | |
| 37Weak | Outset Medical, Inc. | Nabeel Ahmed Chief Financial Officer | $10k 584 shares | -4% | |
| 30Weak | Outset Medical, Inc. | John L. Brottem General Counsel | $7,057 396 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.